The U.S. diagnostic imaging services market represents one of the most critical segments of the healthcare industry, valued at USD 140.21 billion in 2024 and projected to expand to USD 239.74 billion by 2032, reflecting a compound annual growth rate (CAGR) of 7.0% during the forecast period. This robust growth trajectory underscores the essential role that diagnostic imaging plays in modern medical practice, from disease detection to treatment planning and monitoring.
Diagnostic imaging encompasses a diverse array of imaging modalities including Computed Tomography (CT) scans, Magnetic Resonance Imaging (MRI), X-ray, ultrasound, and nuclear medicine scans. These non-invasive techniques provide physicians with critical diagnostic data with high efficiency and safety, making them indispensable tools in contemporary healthcare delivery.
One of the primary drivers propelling market expansion is the unprecedented rise in chronic disease prevalence across the United States. The nation faces a growing burden of conditions such as cancer, cardiovascular disease, neurological disorders, and diabetes, all of which necessitate frequent diagnostic imaging procedures.
According to the American Cancer Society's Cancer Facts & Figures 2024, approximately 25,400 malignant tumors of the brain and spinal cord will be diagnosed in the U.S. in 2024, with roughly 90,000 brain tumors diagnosed annually, of which approximately 28% are malignant. These statistics underscore the critical demand for advanced imaging services in oncology diagnostics.
Cardiovascular disease remains one of the most life-threatening health conditions in the United States. Data from GE Healthcare indicates that more than 20 million U.S. patients experience chest pain annually due to cardiovascular abnormalities, driving substantial demand for cardiac CT imaging procedures. Patients with diabetes face significantly higher risks of developing heart-related complications, further amplifying the need for diagnostic imaging.
The growing aging population significantly contributes to increased demand for diagnostic imaging services. Older adults are more susceptible to chronic diseases and require more frequent diagnostic evaluations, thereby driving utilization rates across all imaging modalities.
Over the past decade, there has been a marked shift toward diagnostic imaging services being conducted in freestanding centers rather than traditional hospital settings. This shift is driven by several compelling factors:
Market leaders are actively expanding their presence through new facility launches. For example, in March 2023, LucidHealth, Inc. launched its 14th outpatient imaging center in Fort Myers, Florida, offering advanced services including 3D mammography and breast biopsies. Similarly, in August 2024, Prisma Health announced the launch of new retail imaging centers in Greenville and West Columbia, offering MRI, CT, and X-ray services at lower costs with flexible scheduling.
Computed Tomography (CT) Dominance: The CT segment holds the largest market share, driven by the rising burden of chronic diseases and the increasing number of CT scan procedures across the nation. The American Cancer Society has projected that 2 million new cancer cases will be diagnosed in the U.S., directly driving demand for CT exams. According to the OECD, the U.S. conducted approximately 84.5 million CT scan procedures in 2021, representing a 15.8% increase from the previous year. Post-pandemic, demand for CT scanners further increased as chest CT scans played a crucial role in diagnosing COVID-19 infections.
X-Ray and MRI Segments: The X-ray segment maintains a moderate market share due to the high incidence of fractures and injuries resulting from road accidents and sports injuries. The MRI segment holds considerable share driven by its increasing use in detecting abnormalities and enabling early diagnosis of neurological disorders and tumors.
Ultrasound and Other Modalities: The ultrasound segment, despite its widespread availability, holds relatively stagnant market share but remains essential for applications such as fetal viewing during pregnancy and detecting urinary tract infections. The "others" segment, including fluoroscopy, PET/CT, SPECT, and nuclear medicine procedures, holds the second-largest market share.
Neurology Leadership: The neurology segment dominated the U.S. market in 2024, driven by the rising prevalence of neurological disorders and strokes. Advanced imaging services play a critical role in confirming and diagnosing neurological conditions. According to the Parkinson's Foundation, approximately 1 million people in the U.S. currently have Parkinson's disease, with projections suggesting this number could reach 1.2 million by 2030.
Oncology and Cardiology Growth: The oncology segment holds the second-largest market share due to the strong prevalence of cancer in the U.S. The cardiology segment is anticipated to grow at the fastest CAGR during the forecast period, driven by increasing cardiovascular cases. The Centers for Disease Control and Prevention (CDC) reports that Heart Valve Disease affects more than 5 million people in the U.S. annually.
Orthopedics and Other Applications: The orthopedics segment maintains considerable market share due to increasing demand for X-rays in diagnosing bone defects and injuries. Gynecology and other segments are expected to grow steadily, driven by rising cases of urinary tract infections and other abdominal abnormalities requiring ultrasound procedures.
Private Insurance Dominance: The private health insurance/out-of-pocket segment dominated the U.S. market in 2024, primarily due to the growing working population opting for private insurance coverage. According to the U.S. Census Bureau, 65.4% of Americans had private health insurance in 2023.
Public Insurance Growth: The public health insurance segment is expected to grow substantially during the forecast period, fueled by expanding government-sponsored insurance programs. The U.S. Census Bureau reports that 36.3% of people in the U.S. were covered under public health insurance in 2023, with this coverage continuing to expand.
Hospital In-Patient Dominance: Hospital in-patient settings dominated the market in 2024, driven by patient preferences for comprehensive diagnosis and treatment under one roof.
Hospital Outpatient (HOPD) and Freestanding Centers Growth: The Hospital Outpatient (HOPD) segment is anticipated to expand at the highest CAGR, driven by patient preference for more cost-effective and convenient options. Freestanding imaging centers are experiencing significant growth due to their reputation for cost-effectiveness, specialized expertise, shorter wait times, and cutting-edge technology.
One of the most significant challenges facing the diagnostic imaging market is the critical shortage of qualified radiologists and imaging specialists. According to the Mammography International Consortium of AI (MICA), drawing from data published by the Association of American Medical Colleges (AAMC), there is an anticipated shortfall of nearly 42,000 radiologists and clinical specialists by 2033.
This shortage is exacerbated by several factors:
This workforce shortage poses a serious challenge to fulfilling the rising demand for imaging procedures and may lead to procedure delays.
Declining reimbursement rates for diagnostic imaging procedures, coupled with rising equipment costs, have placed significant financial strain on small and medium-sized healthcare providers. A study published by the NCBI in September 2024 revealed that Medicare reimbursements for advanced imaging modalities, particularly spinal imaging procedures, experienced significant reductions between 2005 and 2020. This financial pressure limits the ability of smaller facilities to invest in cutting-edge technology and reduces patient access to diagnostic imaging services.
Artificial Intelligence (AI) represents one of the most transformative opportunities in diagnostic imaging. AI algorithms can rapidly analyze vast amounts of imaging data, identifying patterns and abnormalities that might escape human observation. This technology is particularly valuable for:
Market players are increasingly adopting AI to enhance service efficiency. In November 2023, RadNet Inc. launched DeepHealth, an AI-powered health informatics portfolio designed to enhance radiology efficiency. Similarly, in November 2023, Radiology Partners launched its RPX AI orchestration platform on Amazon Web Services (AWS) to simplify AI medical imaging tool deployment.
The industry is experiencing rapid technological advancement, including:
For instance, in February 2024, MedQuest Associates collaborated with GE Healthcare on a three-year initiative to deliver digital tools and advanced medical device technologies for outpatient imaging centers.
The U.S. diagnostic imaging services market is dominated by three major players:
1. RadNet, Inc. RadNet dominates the market with a substantial market share, operating approximately 398 diagnostic imaging centers across the U.S. and annually conducting imaging procedures for around 10 million outpatients. The company's diverse imaging services portfolio and recent acquisition of DeepHealth, Inc. have significantly strengthened its market position and technological capabilities.
2. Akumin, Inc. Ranking second, Akumin has demonstrated strong market performance through its focus on innovation and strategic launches. The company provides hospitals and physician groups with single-modality or multi-modality imaging solutions. In November 2024, Akumin launched Akumin Axis at RSNA 2024, a platform designed to optimize patient access in radiology.
3. Rayus Radiology Rayus Radiology rounds out the top three major players with significant market presence and service offerings.
Additional companies holding substantial market shares include:
The diagnostic imaging services market continues to experience significant consolidation and innovation:
The COVID-19 pandemic initially had a significant negative impact on the diagnostic imaging market in 2020:
However, this decline proved to be primarily short-term, with minimal long-term effects on the fundamental drivers of diagnostic imaging demand. The market began recovery in 2021-2022 and is now positioned for steady growth throughout the 2025-2032 forecast period.
The U.S. diagnostic imaging services market is positioned for robust growth driven by:
The U.S. diagnostic imaging services market stands at a pivotal juncture, balancing substantial growth opportunities against meaningful challenges. With a projected CAGR of 7.0% through 2032, the market is set to expand significantly, driven by increasing disease prevalence, aging populations, technological innovation, and the transformative potential of artificial intelligence.
While challenges such as workforce shortages and declining reimbursement rates require attention, the industry's strong fundamentals and continuous innovation suggest a resilient and expanding market. The shift toward freestanding imaging centers, combined with strategic investments in AI and advanced technologies, positions the market for sustained growth and improved patient access to diagnostic services.
As healthcare continues to evolve, diagnostic imaging will remain central to disease detection, treatment planning, and patient outcomes, ensuring its continued importance and growth within the broader healthcare ecosystem.
Fortune Business Insights. (2025, April 21). *U.S. Diagnostic Imaging Services Market Size, Share & Industry Analysis, By Procedure (CT, MRI, X-Ray, Ultrasound, and Others), By Application (Cardiology, Neurology, Oncology, Orthopedics, Gynecology, and Others), By Payor (Public Health Insurance and Private Health Insurance/Out of Pocket), and By Setting (Hospital In-patient, Hospital Outpatient (HOPD), Freestanding Imaging Centers, and Others), and Country Forecast, 2025-2032.
Retrieved from: https://www.fortunebusinessinsights.com/u-s-diagnostic-imaging-services-market-106552